| __timestamp | GSK plc | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 3450000000 | 242549000 |
| Thursday, January 1, 2015 | 3560000000 | 245098000 |
| Friday, January 1, 2016 | 3628000000 | 147600000 |
| Sunday, January 1, 2017 | 4476000000 | 264600000 |
| Monday, January 1, 2018 | 3893000000 | 357900000 |
| Tuesday, January 1, 2019 | 4568000000 | 1182600000 |
| Wednesday, January 1, 2020 | 5098000000 | 357700000 |
| Friday, January 1, 2021 | 5278000000 | 540100000 |
| Saturday, January 1, 2022 | 5488000000 | 322900000 |
| Sunday, January 1, 2023 | 6223000000 | 408000000 |
Data in motion
In the ever-evolving landscape of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, GSK plc and United Therapeutics Corporation have demonstrated contrasting strategies in their R&D investments. GSK plc, a global healthcare giant, has consistently increased its R&D budget, peaking at approximately $6.2 billion in 2023, marking a 80% rise since 2014. In contrast, United Therapeutics Corporation, a leader in biotechnology, has shown a more volatile R&D expenditure pattern, with a significant spike in 2019, reaching nearly $1.2 billion, before stabilizing around $408 million in 2023. This divergence highlights the differing approaches to innovation: GSK's steady growth versus United Therapeutics' strategic surges. As the pharmaceutical industry continues to face new challenges, these investment patterns offer insights into how companies prioritize innovation to stay competitive.
R&D Spending Showdown: Merck & Co., Inc. vs GSK plc
Research and Development Investment: GSK plc vs Opthea Limited
Who Prioritizes Innovation? R&D Spending Compared for GSK plc and Alpine Immune Sciences, Inc.
R&D Insights: How GSK plc and Protagonist Therapeutics, Inc. Allocate Funds
United Therapeutics Corporation or Sarepta Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: United Therapeutics Corporation vs Halozyme Therapeutics, Inc.
United Therapeutics Corporation or Grifols, S.A.: Who Invests More in Innovation?
Comparing Innovation Spending: United Therapeutics Corporation and Ultragenyx Pharmaceutical Inc.
Research and Development Investment: United Therapeutics Corporation vs Corcept Therapeutics Incorporated
R&D Spending Showdown: United Therapeutics Corporation vs Alkermes plc
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and ImmunityBio, Inc.
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and Bausch Health Companies Inc.